Original Investigation

Telemedicine Preexposure Prophylaxis Prescribing From a Large Online US Company

JAMA Network Open 10.1001/jamanetworkopen.2025.46792

December 01, 2025 at 11:00 AM EST

Read the full article

What are the provision characteristics and magnitude of preexposure prophylaxis care provided via telemedicine (telePrEP) in the US?This cohort study included 162 422 unique individuals who received telePrEP prescriptions from an online company from 2018 through 2025, most of whom had not previously used PrEP. TelePrEP as a proportion of total national PrEP use increased from 2% in 2020 to 19% in 2024.These findings suggest that telePrEP has become a critical part of the HIV prevention infrastructure in the US, highlighting the importance of regulations supporting its provision.

Corresponding Author: Aaron J. Siegler, PhD, Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Rd, Atlanta, GA 30322 (asiegle@emory.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.46792?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120125

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks